Literature DB >> 15088087

[The neurotransmitter, hypocretin. An overview].

C Baumann1, C Bassetti.   

Abstract

Hypocretins (orexins) are recently discovered excitatory neuropeptides produced only in the posterolateral hypothalamus. These neurotransmitters play a key role in sleep-waking regulation. In patients with narcolepsy and cataplexy, hypocretin neurotransmission is deficient, as demonstrated by low or undetectable levels of hypocretin-1 in the cerebrospinal fluid. The etiology of this deficiency is not clear. In most patients with other hypersomnolent syndromes or sleep-waking disturbances, hypocretin neurotransmission is normal. Other functions of the hypocretins include the regulation of food intake and of neuroendocrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15088087     DOI: 10.1007/s00115-003-1631-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  60 in total

1.  A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor.

Authors:  J Arii; T Kanbayashi; Y Tanabe; J Ono; S Nishino; Y Kohno
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

2.  Effects of lateral preoptic area application of orexin-A on sleep-wakefulness.

Authors:  M M Methippara; M N Alam; R Szymusiak; D McGinty
Journal:  Neuroreport       Date:  2000-11-09       Impact factor: 1.837

3.  Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome.

Authors:  R P Allen; E Mignot; B Ripley; S Nishino; C J Earley
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

4.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

5.  Fos expression in orexin neurons varies with behavioral state.

Authors:  I V Estabrooke; M T McCarthy; E Ko; T C Chou; R M Chemelli; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

6.  Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke.

Authors:  T E Scammell; S Nishino; E Mignot; C B Saper
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

7.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness.

Authors:  S Overeem; J J van Hilten; B Ripley; E Mignot; S Nishino; G J Lammers
Journal:  Neurology       Date:  2002-02-12       Impact factor: 9.910

9.  Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats.

Authors:  M R Jain; T L Horvath; P S Kalra; S P Kalra
Journal:  Regul Pept       Date:  2000-02-08

10.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.